Physician profile
Ankit Vyas
NPI 1346862497
$2,664.13
in general payments reported to CMS, 2019-2025
19 companies · $1,337 in 2025
The $1,337 reported for 2025 was more than what 89% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $257 · 2024: $1,070 · 2025: $1,337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,368 · Education: $296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,367.80 |
| Education | $296.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $446.32 | 2023-2025 | Assure Wcd |
| Novo Nordisk INC | $341.58 | 2024-2025 | Wegovy, Ozempic |
| Abbott Laboratories | $339.15 | 2025 | Ensite, Assurity, Cardiomems |
| Novartis Pharmaceuticals Corporation | $239.62 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $236.43 | 2024-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $215.15 | 2023-2024 | Xarelto |
| Amgen INC. | $154.47 | 2023-2024 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $138.03 | 2023-2025 | Jardiance |
| Pfizer INC. | $101.49 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $100.41 | 2023-2024 | Farxiga |
| Abiomed | $66.20 | 2023-2025 | Impella |
| W. L. Gore & Associates, INC. | $50.00 | 2025 | Gore-Tex Vascular Graft |
| Boston Scientific Corporation | $43.44 | 2024 | Watchman Flx |
| Alnylam Pharmaceuticals INC. | $43.02 | 2023-2024 | Onpattro |
| Biosense Webster, INC. | $38.47 | 2025 | Qdot Micro |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $37.78 | 2025 | Azure Xt Dr Mri Surescan |
| Actelion Pharmaceuticals US, INC. | $32.65 | 2024 | Uptravi |
| Inari Medical, INC. | $23.93 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Janssen Scientific Affairs, LLC | $15.99 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankit Vyas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.